Skip to main content

DERM Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Journey Medical Corporation News

Eli Lilly Posts Earnings Beat on Strong Demand for Trulicity and Taltz

Drugmaker Eli Lilly reports fourth-quarter earnings and sales that beat analysts' forecasts as sales of key treatments for diabetes and autoimmune diseases post strong growth.

Stocks End Down on Weaker Jobs Data After Dow Crosses 29,000 for First Time

Stocks finish lower Friday after equities set all-time intraday highs and the Dow tops 29,000 even after the U.S. adds fewer jobs than expected to payrolls in December.

Eli Lilly to Buy Skin Treatment Company Dermira for $1.1 Billion

Eli Lilly will buy Dermira for $1.1 billion in cash, or $18.75 a share.

Rally Runs Low on Fuel: Cramer's 'Mad Money' Recap

Cramer says rallies need fuel, and without it, we end up with what we got Tuesday: a soggy session that reminds us stocks can go down, too.

Yeti Holdings, Canopy Growth, Dermira: 'Mad Money' Lightning Round

Jim Cramer takes a look at Yeti Holdings, Canopy Growth, Dermira, Daktronics, TherapeuticsMD, Rite Aid, Genpact and California Water Services.

Breaking News

Las Vegas Strip May Lose a Major Sports Franchise

Sin City usually gets what it wants. That may not happen this time.

Steve Jobs Gets Posthumous Award From President Joe Biden

Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.

Target Has a Surprising New Idea For Cereal Fans

This throwback will excite fans who fondly remember cereals from their childhoods.

TikTok Faces a New Major Threat

The popular short-form social media company is in the hot seat once again in the U.S.